News & Events

Dec 15, 2017

CIRM Grants ViaCyte $1.4M to Create Immune-Evasive Pluripotent Stem Cell Lines

Read More
Dec 06, 2017

ViaCyte Selected as a Winner of CONNECT’s 30th Annual Most Innovative New Product Awards

Read More
Oct 04, 2017

ViaCyte to Present at Upcoming Investor and Partnering Events in October

Read More
Sep 28, 2017

ViaCyte Awarded New CIRM Grant to Support Clinical Trial of PEC-Direct Product Candidate for High-Risk Type 1 Diabetes

Read More
Sep 21, 2017

ViaCyte Selected as a Finalist for CONNECT’s 30th Annual Most Innovative New Product Awards

Read More
Sep 07, 2017

ViaCyte to Present at Upcoming Scientific Meetings on Diabetes Research

Read More
Aug 01, 2017

ViaCyte Announces First Patients Implanted with PEC-Direct Islet Cell Replacement Therapy in International Clinical Trial

Read More
Jun 15, 2017

ViaCyte Presents at the ISSCR 2017 Annual Meeting in Boston

Read More
May 22, 2017

ViaCyte Receives IND Allowance from FDA and Clearance from Health Canada to Commence International Clinical Trial of PEC-Direct Cell Therapy for High-Risk Type 1 Diabetes

Read More
May 22, 2017

ViaCyte Announces $10 Million in Financing

Read More
May 22, 2017

JDRF and ViaCyte Announce Support for Development of PEC-Direct Cell Replacement Therapy for Type 1 Diabetes

Read More
Apr 24, 2017

ViaCyte to Present at ARM’s 5th Annual Cell & Gene Therapy Investor Day in Boston

Read More
Mar 29, 2017

ViaCyte and W. L. Gore & Associates Announce Collaborative Research Agreement to Develop Novel Implantable Delivery Technologies for Cell Therapies

Read More
Feb 23, 2017

Beyond Type 1 Provides Grant to ViaCyte to Support Research and Development of Cell Replacement Therapies for Type 1 Diabetes

Read More
Feb 21, 2017

ViaCyte to Present at Four Upcoming Healthcare Events

Read More
Jan 04, 2017

Twenty-two New Patents Are Added To ViaCyte’s Intellectual Property Portfolio

Read More

Media Materials

Contact Us

All Years